By Marcus A. Banks
The Drug Enforcement Administration (DEA) and the Department of Health and Human Services’ Substance Abuse and Mental Health Services Administration (SAMHSA) extended the ability for clinicians to prescribe controlled medications for conditions such as opioid use disorder (OUD), pain and anxiety via telemedicine, without first seeing a patient in person, on May 9, 2023. This flexibility had been set to expire on May 11, as the COVID-19 Public Health Emergency (PHE)
MAY 25, 2023